Suzhou Ribo Life Science Co., Ltd

Established in 2007, Suzhou Ribo Life Science Co., Ltd. (Ribo) is a clinical stage company devoted to the development of innovative RNAi technologies and oligonucleotide therapeutics as an effort to address unmet clinical needs in the world with the tools, capacity and RNA therapeutics that we build up in China. Fueled by our mission to make Chinas oligonucleotide therapeutics serve the world, we seek. Based on its cutting edge RNAi technologies, Ribo has established oligonucleotide therapeutic platform that vertically integrates the complete set of technologies to support the full life cycle of oligonucleotide therapeutics from early R&D to commercialization

Rna therapeutics,sirna,aso,aptamer,cmc,cardiometabolic diseases,and liver diseases

Suzhou ribo life science co., ltd operates in the Biotechnology research industry.

Suzhou ribo life science co., ltd's revenue is 11m - 100m

Suzhou ribo life science co., ltd has 11 - 50 employees.